Based on recent data, Quantum BioPharma Ltd. (QNTM) shows an Average True Range (ATR) of 0.38 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 202.25K, indicating liquidity. These fundamental metrics provide insight into QNTM's underlying financial health and market activity.
| ATR | 0.38 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 202.25K |
| Avg Vol (10 Days) | 727.86K |
Quantum BioPharma Ltd. (QNTM) technical indicators as of March 24, 2026: the SMA 20 is -8.62%, SMA 50 at -40.45%, and SMA 200 at -73.7%. The RSI 14 value is 30.28, suggesting its current momentum. These technical analysis signals help assess QNTM's price trends and potential future movements.
| SMA 20 | -8.62% |
| SMA 50 | -40.45% |
| SMA 200 | -73.7% |
| RSI 14 | 30.28 |
Quantum BioPharma Ltd. (QNTM) stock performance overview as of March 24, 2026: The 52-week high is $38.25 (currently -90.64% below), and the 52-week low is $2.07 (currently 1.9% above). Over the past year, QNTM's performance is 118.13%, compared to the S&P 500's 14.52% change.
| 52-Week High | 38.25 |
| 52-Week High Chg | -90.64% |
| 52-Week Low | 2.07 |
| 52-Week Low Chg | +1.90% |
| S&P 500 52-Week Chg | 14.52% |
According to market data, Quantum BioPharma Ltd. (QNTM) stock's recent performance metrics show that over the last month, QNTM is -12.8%, with a Year-to-Date (YTD) performance of -1.1%. Over the past year, the stock has seen a 118.13% change. These figures summarize QNTM's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.83 | 4.83 | 11.49 | 21 | 38.25 | 7.65 |
| Low | 2.18 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 |
| Performance | +3.74% | -12.80% | -49.01% | -69.55% | +118.13% | -1.10% |
According to current financial data, QNTM stock's P/E (TTM) ratio is -0.60, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for QNTM, including P/S (N/A), P/B (1.98), and P/FCF (-1.98), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | QNTM | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.6 | -1.23 | 13.14 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 6.11 | 5.98 |
| P/B (TTM) | 1.98 | 0 | 20.29 | 4.69 |
| P/FCF (TTM) | -1.98 | 78.11 | 66.38 | 32.63 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep